Could a diabetes drug tame PCOS inflammation better than standard care?
Disease control
Completed
This study looked at whether a newer diabetes drug, called an SGLT2 inhibitor, can improve symptoms of Polycystic Ovary Syndrome (PCOS) better than the standard medicine metformin. PCOS involves chronic inflammation, and the drug may work by reducing that inflammation. The trial …
Phase: NA • Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated May 01, 2026 16:01 UTC